{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T01:33:30Z","timestamp":1755221610544,"version":"3.43.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,8]]},"DOI":"10.7759\/cureus.89652","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T01:55:41Z","timestamp":1754704541000},"source":"Crossref","is-referenced-by-count":0,"title":["Stepwise Management of Status Asthmaticus Refractory to Initial Therapy: A Case Report"],"prefix":"10.7759","author":[{"given":"Brandon","family":"Weissman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shafayath","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","unstructured":"GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020, 396:1204-22. 10.1016\/S0140-6736(20)30925-9","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198902023200502","article-title":"Association of asthma with serum IgE levels and skin-test reactivity to allergens","volume":"320","author":"Burrows B","year":"1989","unstructured":"Burrows B, Martinez FD, Halonen M, Barbee RA, Cline MG. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med. 1989, 320:271-7. 10.1056\/NEJM198902023200502","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/144.1.51","article-title":"Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics: cellular, mediator, and permeability changes","volume":"144","author":"Liu MC","year":"1991","unstructured":"Liu MC, Hubbard WC, Proud D, et al.. Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics: cellular, mediator, and permeability changes. Am Rev Respir Dis. 1991, 144:51-8. 10.1164\/ajrccm\/144.1.51","journal-title":"Am Rev Respir Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1172\/JCI5909","article-title":"Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production","volume":"103","author":"Zhu Z","year":"1999","unstructured":"Zhu Z, Homer RJ, Wang Z, et al.. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest. 1999, 103:779-88. 10.1172\/JCI5909","journal-title":"J Clin Invest"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00950.2012","article-title":"Airway smooth muscle in the pathophysiology and treatment of asthma","volume":"114","author":"Doeing DC","year":"2013","unstructured":"Doeing DC, Solway J. Airway smooth muscle in the pathophysiology and treatment of asthma. J Appl Physiol (1985). 2013, 114:834-43. 10.1152\/japplphysiol.00950.2012","journal-title":"J Appl Physiol (1985)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s40413-018-0196-1","article-title":"Appropriateness of chronic asthma management and medication adherence in patients visiting ambulatory clinic of Gondar University Hospital: a cross-sectional study","volume":"11","author":"Tesfaye ZT","year":"2018","unstructured":"Tesfaye ZT, Gebreselase NT, Horsa BA. Appropriateness of chronic asthma management and medication adherence in patients visiting ambulatory clinic of Gondar University Hospital: a cross-sectional study. World Allergy Organ J. 2018, 11:18. 10.1186\/s40413-018-0196-1","journal-title":"World Allergy Organ J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.ss7005a1","article-title":"Asthma surveillance - United States, 2006-2018","volume":"70","author":"Pate CA","year":"2021","unstructured":"Pate CA, Zahran HS, Qin X, Johnson C, Hummelman E, Malilay J. Asthma surveillance - United States, 2006-2018. MMWR Surveill Summ. 2021, 70:1-32. 10.15585\/mmwr.ss7005a1","journal-title":"MMWR Surveill Summ"},{"key":"ref8","article-title":"Status Asthmaticus","author":"Chen RJ","year":"2025","unstructured":"Chen RJ, Launico MV. Status Asthmaticus. StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000052.pub3","article-title":"Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma","volume":"2013","author":"Cates CJ","year":"2013","unstructured":"Cates CJ, Welsh EJ, Rowe BH. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev. 2013, 2013:CD000052. 10.1002\/14651858.CD000052.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-013-8395-6","article-title":"Definition of critical asthma syndromes","volume":"48","author":"Kenyon N","year":"2015","unstructured":"Kenyon N, Zeki AA, Albertson TE, Louie S. Definition of critical asthma syndromes. Clin Rev Allergy Immunol. 2015, 48:1-6. 10.1007\/s12016-013-8395-6","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.152.3.7663795","article-title":"Beta-adrenergic receptors and their regulation","volume":"152","author":"Barnes PJ","year":"1995","unstructured":"Barnes PJ. Beta-adrenergic receptors and their regulation. Am J Respir Crit Care Med. 1995, 152:838-60. 10.1164\/ajrccm.152.3.7663795","journal-title":"Am J Respir Crit Care Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.01199.x","article-title":"Glucocorticosteroids: current and future directions","volume":"163","author":"Barnes PJ","year":"2011","unstructured":"Barnes PJ. Glucocorticosteroids: current and future directions. Br J Pharmacol. 2011, 163:29-43. 10.1111\/j.1476-5381.2010.01199.x","journal-title":"Br J Pharmacol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2005.047803","article-title":"Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis","volume":"60","author":"Rodrigo GJ","year":"2005","unstructured":"Rodrigo GJ, Castro-Rodriguez JA. Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis. Thorax. 2005, 60:740-6. 10.1136\/thx.2005.047803","journal-title":"Thorax"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010179","article-title":"Addition of intravenous beta(2)-agonists to inhaled beta(2)-agonists for acute asthma","volume":"12","author":"Travers AH","year":"2012","unstructured":"Travers AH, Milan SJ, Jones AP, Camargo CA Jr, Rowe BH. Addition of intravenous beta(2)-agonists to inhaled beta(2)-agonists for acute asthma. Cochrane Database Syst Rev. 2012, 12:CD010179. 10.1002\/14651858.CD010179","journal-title":"Cochrane Database Syst Rev"},{"key":"ref15","article-title":"Rocuronium","author":"Jain A","year":"2024","unstructured":"Jain A, Wermuth HR, Dua A, Singh K, Maani CV. Rocuronium. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-020-00455-2","article-title":"Neuromuscular blockade management in the critically ill patient","volume":"8","author":"Renew JR","year":"2020","unstructured":"Renew JR, Ratzlaff R, Hernandez-Torres V, Brull SJ, Prielipp RC. Neuromuscular blockade management in the critically ill patient. J Intensive Care. 2020, 8:37. 10.1186\/s40560-020-00455-2","journal-title":"J Intensive Care"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4103\/0972-5229.117048","article-title":"Ketamine in status asthmaticus: a review","volume":"17","author":"Goyal S","year":"2013","unstructured":"Goyal S, Agrawal A. Ketamine in status asthmaticus: a review. Indian J Crit Care Med. 2013, 17:154-61. 10.4103\/0972-5229.117048","journal-title":"Indian J Crit Care Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2109060","article-title":"Beta-agonist intrinsic efficacy: measurement and clinical significance","volume":"165","author":"Hanania NA","year":"2002","unstructured":"Hanania NA, Sharafkhaneh A, Barber R, Dickey BF. Beta-agonist intrinsic efficacy: measurement and clinical significance. Am J Respir Crit Care Med. 2002, 165:1353-8. 10.1164\/rccm.2109060","journal-title":"Am J Respir Crit Care Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1164\/arrd.1984.129.5.856","article-title":"Anticholinergic, antimuscarinic bronchodilators","volume":"129","author":"Gross NJ","year":"1984","unstructured":"Gross NJ, Skorodin MS. Anticholinergic, antimuscarinic bronchodilators. Am Rev Respir Dis. 1984, 129:856-70. 10.1164\/arrd.1984.129.5.856","journal-title":"Am Rev Respir Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2011.600689","article-title":"Montelukast for the treatment of asthma in the adult population","volume":"12","author":"Amlani S","year":"2011","unstructured":"Amlani S, Nadarajah T, McIvor RA. Montelukast for the treatment of asthma in the adult population. Expert Opin Pharmacother. 2011, 12:2119-28. 10.1517\/14656566.2011.600689","journal-title":"Expert Opin Pharmacother"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/363337-stepwise-management-of-status-asthmaticus-refractory-to-initial-therapy-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T01:55:42Z","timestamp":1754704542000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/363337-stepwise-management-of-status-asthmaticus-refractory-to-initial-therapy-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.89652","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,8]]}}}